Synthesis of novel 7-oxabicyclo[2.2.1]-heptane thromboxane A(2) derivatives containing substitution on positions one and two

被引:0
作者
Kan, WM
Yek, YL
机构
来源
EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY 3 | 1997年 / 407卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:497 / 501
页数:5
相关论文
共 13 条
[1]  
HALUSHKA P V, 1989, Drugs of Today, V25, P383
[2]   SPECIFIC RECEPTORS FOR THROMBOXANE-A2 IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS OF RAT AORTA [J].
HANASAKI, K ;
NAKANO, K ;
KASAI, H ;
ARITA, H ;
OHTANI, K ;
DOTEUCHI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 150 (03) :1170-1175
[3]  
HEDBERG A, 1988, J PHARMACOL EXP THER, V245, P786
[4]   CLONING AND EXPRESSION OF CDNA FOR A HUMAN THROMBOXANE-A2 RECEPTOR [J].
HIRATA, M ;
HAYASHI, Y ;
USHIKUBI, F ;
YOKOTA, Y ;
KAGEYAMA, R ;
NAKANISHI, S ;
NARUMIYA, S .
NATURE, 1991, 349 (6310) :617-620
[5]   EP-171 - A HIGH-AFFINITY THROMBOXANE-A2-MIMETIC, THE ACTIONS OF WHICH ARE SLOWLY REVERSED BY RECEPTOR BLOCKADE [J].
JONES, RL ;
WILSON, NH ;
LAWRENCE, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) :875-887
[6]   INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANE OXAZOLES - HIGHLY POTENT, SELECTIVE, AND LONG-ACTING THROMBOXANE A(2)-RECEPTOR ANTAGONISTS [J].
MISRA, RN ;
BROWN, BR ;
SHER, PM ;
PATEL, MM ;
HALL, SE ;
HAN, WC ;
BARRISH, JC ;
KOCY, O ;
HARRIS, DN ;
GOLDENBERG, HJ ;
MICHEL, IM ;
SCHUMACHER, WA ;
WEBB, ML ;
MONSHIZADEGAN, H ;
OGLETREE, ML .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1401-1417
[7]  
MURAIYAMA T, 1981, CHEM LETT, P29
[8]   REGULATION OF THROMBOXANE RECEPTOR ACTIVATION IN HUMAN-PLATELETS [J].
MURRAY, R ;
FITZGERALD, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :124-128
[9]  
OLGETREE ML, 1993, J PHARMACOL EXP THER, V264, P570
[10]  
RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256